Jacob Haaber

472 total citations
13 papers, 336 citations indexed

About

Jacob Haaber is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Jacob Haaber has authored 13 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in Jacob Haaber's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Multiple Myeloma Research and Treatments (3 papers). Jacob Haaber is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Multiple Myeloma Research and Treatments (3 papers). Jacob Haaber collaborates with scholars based in Denmark, Norway and Finland. Jacob Haaber's co-authors include T. Rasmussen, Lene Meldgaard Knudsen, Marianne Lodahl, Jean‐Marie Delaissé, Gitte Kerndrup, Teis Esben Søndergaard, Steen Kølvraa, Patrice Boissy, Torben Plesner and Pär Josefsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Journal of Pathology.

In The Last Decade

Jacob Haaber

11 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob Haaber Denmark	8	192	124	105	87	64	13	336
Olivier Catalani Switzerland	11	198 1.0×	116 0.9×	76 0.7×	165 1.9×	151 2.4×	17	457
Luk Cox Belgium	9	99 0.5×	86 0.7×	195 1.9×	115 1.3×	97 1.5×	12	432
Ilaria Silvestris Italy	9	56 0.3×	70 0.6×	124 1.2×	68 0.8×	98 1.5×	23	281
Natalie Galanina United States	9	166 0.9×	164 1.3×	78 0.7×	42 0.5×	148 2.3×	20	377
Rapp Mj France	6	184 1.0×	104 0.8×	153 1.5×	246 2.8×	77 1.2×	9	421
Takaaki Chou Japan	9	122 0.6×	91 0.7×	33 0.3×	48 0.6×	63 1.0×	20	236
Athanasios Thomaides United States	8	141 0.7×	134 1.1×	124 1.2×	24 0.3×	35 0.5×	20	328
Carol Ward United Kingdom	8	110 0.6×	56 0.5×	52 0.5×	40 0.5×	71 1.1×	13	259
Simon Husby Denmark	7	184 1.0×	258 2.1×	79 0.8×	57 0.7×	177 2.8×	22	369
Keiichiro Hattori Japan	12	97 0.5×	186 1.5×	68 0.6×	88 1.0×	96 1.5×	35	346

Countries citing papers authored by Jacob Haaber

Since Specialization

Citations

This map shows the geographic impact of Jacob Haaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Haaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Haaber more than expected).

Fields of papers citing papers by Jacob Haaber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Haaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Haaber. The network helps show where Jacob Haaber may publish in the future.

Co-authorship network of co-authors of Jacob Haaber

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Haaber. A scholar is included among the top collaborators of Jacob Haaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Haaber. Jacob Haaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Grantzau, Trine, Mia Dahl Sørensen, Michael Møller, et al.. (2025). Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies. PubMed. 2(3). 100096–100096.

Bentzen, Hans, Jon Riise, Jacob Haaber, et al.. (2025). Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long‐term follow‐up of the Nordic Lymphoma Group MCL6 Philemon trial. HemaSphere. 9(3). e70101–e70101.

Cédile, Oriane, Marcus Høy Hansen, Christian Nielsen, et al.. (2022). Exploration of residual disease in stem cell products from mantle cell lymphoma using next-generation sequencing. Leukemia Research Reports. 18. 100341–100341. 1 indexed citations

Hansen, Marcus Høy, Oriane Cédile, Michael Møller, et al.. (2021). Detailed characterization of the transcriptome of single B cells in mantle cell lymphoma suggesting a potential use for SOX4. Scientific Reports. 11(1). 19092–19092. 4 indexed citations

Hansen, Marcus Høy, et al.. (2021). Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma. SHILAP Revista de lepidopterología. 15. 100255–100255. 2 indexed citations

Hansen, Marcus Høy, Oriane Cédile, Lene Hyldahl Ebbesen, et al.. (2020). Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma. Experimental Hematology. 84. 7–18.e12. 7 indexed citations

Lenz, Georg, Eliza A. Hawkes, Gregor Verhoef, et al.. (2020). Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma. Leukemia. 34(8). 2184–2197. 52 indexed citations

Eskelund, Christian Winther, Konstantinos Dimopoulos, Arne Kolstad, et al.. (2020). Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3. HemaSphere. 5(1). e510–e510. 17 indexed citations

Bæch, Joachim, Steen Møller Hansen, Peter de Nully Brown, et al.. (2018). Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines. British Journal of Haematology. 183(5). 717–726. 44 indexed citations

10.

Arboe, Bente, Pär Josefsson, Judit Jørgensen, et al.. (2016). Danish National Lymphoma Registry. Clinical Epidemiology. Volume 8. 577–581. 47 indexed citations

11.

Rasmussen, T., Jacob Haaber, I. M. Dahl, et al.. (2010). Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma. Haematologica. 95(10). 1730–1737. 38 indexed citations

12.

Haaber, Jacob, Niels Abildgaard, Lene Meldgaard Knudsen, et al.. (2007). Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis. British Journal of Haematology. 140(1). 25–35. 38 indexed citations

13.

Boissy, Patrice, Teis Esben Søndergaard, Torben Plesner, et al.. (2006). Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer–host partnership?. The Journal of Pathology. 211(1). 10–17. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact